These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38156861)

  • 1. Suppressor of Cytokine Signaling-3 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients in Egypt.
    El Sharnoby A; Bedair HM; Raia GYS; Hamed N; Sabry A; Khalaf FA; Abd Elhamed MR; Abdel-Samiee M
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4253-4261. PubMed ID: 38156861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
    Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients.
    Abdel Allah HMM; Zahran WE; El-Masry SA; El-Bendary M; Soliman AF
    Clin Exp Med; 2022 May; 22(2):257-267. PubMed ID: 34297238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.
    Zekri AR; Salama H; Medhat E; Bahnassy AA; Morsy HM; Lotfy MM; Ahmed R; Darwish T; Marei MS
    Asian Pac J Cancer Prev; 2014; 15(17):7213-8. PubMed ID: 25227816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
    Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
    J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
    Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
    Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
    Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
    El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
    BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
    Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
    Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
    Bakr NM; Awad A; A Moustafa E
    IUBMB Life; 2018 Feb; 70(2):165-174. PubMed ID: 29341496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in DNA-repair genes (XRCC1, 3, and 7) and the susceptibility to hepatocellular carcinoma in a cohort of Egyptians.
    Aboul Enein AA; Khaled IAA; Khorshied MM; Abdel-Aziz AO; Zahran N; El Saeed AM; Shousha HI; Abdel Rahman HA
    J Med Virol; 2020 Dec; 92(12):3609-3616. PubMed ID: 32281666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.